Last reviewed · How we verify

NCT03965507

The Prevalence Of Sacroiliac Joint Dysfunction In Patients With Lumbar Disc Hernia

Completed Last updated 31 May 2019
What this trial tests

trial testing Evaluation of the prevalence of sacroiliac joint dysfunction in lumbar disc herniation in Lumbar Disc Herniation in 234 participants. Completed in 16 April 2015.

Timeline
22 January 2015
Primary endpoint
16 April 2015
16 April 2015

Quick facts

Lead sponsorEuropean University of Lefke
StatusCompleted
Study typeOBSERVATIONAL
Enrollment234
Start date22 January 2015
Primary completion16 April 2015
Estimated completion16 April 2015

Drugs / interventions tested

Conditions studied

Sponsor

European University of Lefke

Who can join

Adults 20 to 60, any sex, with Lumbar Disc Herniation or Sacroiliac Joint Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study evaluated the prevalence of sacroiliac joint dysfunction in patients with lumbar disc hernia and examined the variations in clinical parameters cause by this combination.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Lumbar Disc Herniation

Currently open trials in the same condition.

Other European University of Lefke trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03965507.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing